scispace - formally typeset
Search or ask a question
Institution

BIA Separations (Slovenia)

CompanyLjubljana, Slovenia
About: BIA Separations (Slovenia) is a company organization based out in Ljubljana, Slovenia. It is known for research contribution in the topics: Monolithic HPLC column & Monolith. The organization has 84 authors who have published 152 publications receiving 4883 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: In this work, methacrylate-based monolithic columns with the bed volume up to 8000 ml are characterized and are found to be incompressible under these operating conditions and resistant to strong alkaline conditions.

75 citations

Journal ArticleDOI
TL;DR: In this article, the dynamic binding capacity of CIM® monolithic columns has been characterized for different linear velocities, up to a linear velocity of 2450 cm/h. Breakthrough experiments were performed for capacity determination.
Abstract: The characterization of CIM® DEAE monolithic columns in terms of dynamic binding capacity is presented in this paper. Breakthrough experiments were performed for capacity determination. Bovine serum albumin (BSA) was used as a model protein. It is shown that CIM® monolithic columns have good batch-to-batch reproducibility as well as long-term stability. The experiments performed under different linear velocities demonstrated that the dynamic capacity is unaffected at least up to a linear velocity of 2450 cm/h. Furthermore, the breakthrough curve slope is constant, indicating that the capacity would remain constant at even higher linear velocities. The adsorption isotherm of BSA dissolved in 20 mM Tris-HCl buffer shows a constant capacity of around 30 mg/mL of support down to a concentration of 20 μg/mL. The capacity is substantially influenced by the ionic strength; however, 20% of the maximal capacity is still preserved at 0.3 M NaCl.

74 citations

Journal ArticleDOI
TL;DR: Convective Interaction Media short monolithic columns (SMC) that are based on methacrylate monoliths exhibit some interesting features that make them attractive for these tasks, and applications of SMC for the separation and purification of large biomolecules are presented.
Abstract: New therapeutics that are being developed rely more and more on large and complex biomacromolecules like proteins, DNA, and viral particles. Manufacturing processes are being redesigned and optimized both upstream and downstream to cope with the ever-increasing demand for the above target molecules. In downstream processing, LC still represents the most powerful technique for achieving high yield and high purities of these molecules. In most cases, however, the separation technology relies on conventional particle-based technology, which has been optimized for the purification of smaller molecules. New technologies are, therefore, needed in order to push the downstream processing ahead and into the direction that will provide robust, productive, and easy to implement methods for the production of novel therapeutics. New technologies include the renaissance of membranes, various improvements of existing technologies, but also the introduction of a novel concept--the continuous bed or monolithic stationary phases. Among different introduced products, Convective Interaction Media short monolithic columns (SMC) that are based on methacrylate monoliths exhibit some interesting features that make them attractive for these tasks. SMC can be initially used for fast method development on the laboratory scale and subsequently efficiently transferred to preparative and even more importantly to industrial scale. A brief historical overview of methacrylate monoliths is presented, followed by a short presentation of theoretical considerations that had led to the development of SMC. The design of these columns, as well as their scale-up to large units, together with the methods for transferring gradient separations from one scale to another are addressed. Noninvasive methods that have been developed for the physical characterization of various batches of SMC, which fulfill the regulatory requirements for cGMP production, are discussed. The applications of SMC for the separation and purification of large biomolecules, which demonstrate the full potential of this novel technology for an efficient downstream processing of biomolecules, are also presented.

71 citations

Journal ArticleDOI
TL;DR: Methacrylate monoliths (Convective Interaction Media monolithic columns) were applied for the purification of Staphylococcus aureus phages VDX-10 from bacterial lysate, resulting in more than 99% of host cell DNA and more than 90% of proteins were removed, with 60% recovery of viable phages.

71 citations

Journal ArticleDOI
TL;DR: In this paper, the effect of various methacrylate monomers on the porous structure of the monolith was investigated, and the porosity of the porous structures was correlated with the specific surface area, pressure drop, and dynamic binding capacity.
Abstract: Methacrylate-based monoliths are formed during radical copolymerization as a consequence of the precipitation of polymeric chains from the reaction mixture, which consists of monomers, initiator, and the porogenic solvents. The effect of various methacrylate monomers on the porous structure of the monolith was investigated. Although the chemical structure of the monomers significantly affects the size of the pores and the porosity, the mechanism of pore formation in the case of the precipitation during polymerization is preserved. The porous structure was further correlated with the specific surface area, pressure drop, and dynamic binding capacity of the monoliths studied.

67 citations


Authors

Showing all 84 results

NameH-indexPapersCitations
Aleš Štrancar381223748
Djuro Josic361774580
Aleš Podgornik36903274
Thomas Muster33677766
Miloš Barut23451500
Matjaž Peterka17321222
Petra Kramberger1423642
Janez Jančar1114425
Jana Vidič1019686
Nika Lendero Krajnc1019395
Urh Černigoj925267
Rok Košir914456
Peter Brne88330
Marko Banjac710206
Lidija Urbas78241
Network Information
Related Institutions (5)
Hoffmann-La Roche
43K papers, 1.6M citations

80% related

Merck & Co.
48K papers, 1.9M citations

79% related

Food and Drug Administration
19.5K papers, 691.2K citations

79% related

Bristol-Myers Squibb
21K papers, 932.5K citations

77% related

Pfizer
37.4K papers, 1.6M citations

77% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20219
20203
20193
20184
201712
20168